Please assess the completion status of the following clinical trial:

Trial Title: Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged from 1 to 4 years old~* Male or female~* With medically diagnosed asthma~* Patients who are used to use an inhalation chamber with a face mask~* Patients who have not had asthmatic decompensation for at least 1 month.~* Patients' parents having given their written consent~* With normal clinical respiratory examination on the day of the test.~Exclusion Criteria:~* Patients whose parents are unable to understand the purpose and conditions of the study~* Patients whose parents are unable to give their consent~* Patients participating in another clinical trial or exclusion period from a previous clinical trial~* Patients presenting with a nasopharyngeal infection in the previous month~* Child with nasal obstruction, nocturnal snoring, adenoid facies or facial malformation~* Patient presenting with an asthmatic decompensation episode in the previous month

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 4 Years
- Healthy Volunteers: f

Study Arms:
- Flixotide (Type: EXPERIMENTAL): Patients inhale first Flixotide and then Qvar
- Qvar (Type: EXPERIMENTAL): Patients inhale first Qvar and then Flixotide

Based on this trial design, predict the completion outcome and termination type (if applicable).